Some of the earliest, published studies on sweat composition date back to the 19th century. Further studies in the 20th century began to solidify understanding of the physiology and pharmacology of the eccrine sweat gland. In-vivo and in-vitro studies from this time period, and even those continuing today, have identified numerous structural nuances and new molecules present within sweat. The first commercially adopted use for sweat diagnostics included testing of sodium and chloride levels in children for the diagnosis of cystic fibrosis. Today, one of the most popular devices for this testing is the Macroduct Sweat Collection System from ELITechGroup.
General evidence
More recently, numerous studies have identified the plausibility of sweat as an alternative to blood analysis. The potential substitution for sweat versus blood analysis has many potential benefits. For example, sweat can be: extracted in a non-invasive manner via iontophoresis; extracted with little-to-no pain; and monitored continuously. There are downfalls to the technology, however. For example, demonstration of successful and reliable sweat extraction and analysis on a cohesive device has yet to be demonstrated. Furthermore, although some biomarker partitioning mechanisms are well understood and well studied, partitioning of other useful biomarkers are less understood.
Current research
Portable devices
Patches
Patches have been demonstrated to be a promising detection platform for sweat diagnostics. Simple, long-term collection devices which check for drugs of abuse or alcohol are already on the market and operate on the following principle: a user applies the patch which then collects sweat over a period of hours or days, then the patch is analyzed utilizing techniques such as GC-MS which are accurate but the suffer the drawback in lack of continuous measurements and high costs. For example, drugs of abuse and alcohol sweat testing are provided by PharmChem and AlcoPro, respectively. Recently several efforts have been made to develop low cost polymer based continuous perspiration monitoring devices and are in early stages of commercialization. More recently, several startup companies such as or have begun developing products targeted towards the consumer, healthcare and athletics market for sweat diagnostics. Ultimately, it is the hope that these devices will have the ability to detect changes in human physiology within minutes without the need for repeated sample collection and analysis.
